Current Treatment Options for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Investigators summarize current literature surrounding the treatment of NLPHL and discuss treatment considerations for 2 clinical cases.
Lymphoma
LYMPHOMA ADVISOR
FEATURED CONTENT
-
-
No Need for Radiotherapy in Hodgkin Lymphoma With Negative PET Scan
Even patients with bulky disease had no difference in survival after chemotherapy, provided their PET scan was negative. -
On-Body Injections of Pegfilgrastim May Not Always Be Preferred — But They’re On Schedule
Preferences are tied not just to the experience of receiving an injection, but also to factors related to a patient’s access to different types of care settings. -
Radiation May Be a Useful Bridging Therapy to CAR-T Treatment in Relapsed/Refractory Non-Hodgkin Lymphoma
A new study suggests that radiation prior to CAR-T infusion is a safe bridging therapy — and this approach may even decrease some of the immunotherapy’s side effects, researchers hypothesize. -
Why It’s Been So Hard to Conclusively Link Environmental Factors to Non-Hodgkin Lymphoma
Small studies, the absence of subtypes, and a historical lack of genetic information has stopped past studies from triggering meaningful public health change, a review asserts.
VIDEO SERIES
LYMPHOMA NEWS
Idelalisib Does not Increase Risk for Bleeding in Patients With CLL, Indolent NHL Receiving Anticoagulation/Antiplatelet Therapy
Biosimilar Riabni Gets FDA Approval
Intensive Chemotherapy Tolerable, Efficacious in HIV-Associated Burkitt Lymphoma
Mantle Cell Lymphoma: Long-Extending Remissions With Lenalidomide, Rituximab
Older Patients With NHL Are at Higher Risk for Hospitalization vs Non-Cancer Controls
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Lymphoma
